Optimize therapeutic effects of tumor vaccines by viruses and bacteria

发布时间:2015-06-17浏览次数:828

报告题目:Optimize therapeutic effects of tumor vaccines by viruses and bacteria

报告人:Dr. Zhao Lixiang

报告时间:2015年06月24日(周三)14:00

报告地点:新威尼斯v0008独墅湖校区医学楼403-3120

报告人简介:

     Dr. Zhao received his Bachelor (2002), Master (2005) and PhD degrees (2008) from Yangzhou University. Afterwards, he joined IBMS of Soochow University in 2008 as a lecturer. He was promoted to associate professor in 2014. Dr. Zhao has focused on tumor immunology, especially tumor immunotherapy.

近三年发表论文:

1. Zhao L., Mei Y., Sun Q., Guo L., Wu Y., Yu X., Hu B., Liu X., Liu H. 2014. Autologous tumor vaccine modified with recombinant new castle disease virus expressing IL-7 promotes antitumor immune response. Journal of Immunology. 193: 735-45.

2. Sun Q, Zhao L, Song Q, Wang Z, Qiu X, Zhang W, Zhao M, Zhao G, Liu W, Liu H, Li Y, Liu X. 2012. Hybrid- and complex-type N-glycans are not essential for Newcastle disease virus infection and fusion of host cells. Glycobiology. 22(3): 369-378. (Co-first author)

3. Zhao L., Liu H. 2012. Newcastle disease virus: a promising agent for tumor immunotherapy. Clin Exp Pharmacol Physiol. 39(8): 725-30.